Literature DB >> 23686232

The antiviral activities of tetherin.

Stuart J D Neil1.   

Abstract

Tetherin (BST2/CD317) has emerged as a key host cell defense molecule, inhibiting the release and spread of diverse enveloped virions from infected cells. In this chapter, I review the molecular and cellular basis for tetherin's antiviral activities and the function of virally encoded countermeasures that disrupt its function. I further describe recent advances in our understanding of tetherin's associated role in viral pattern recognition and the evidence for its role in limiting viral pathogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23686232     DOI: 10.1007/978-3-642-37765-5_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  61 in total

Review 1.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

2.  Basic motifs target PSGL-1, CD43, and CD44 to plasma membrane sites where HIV-1 assembles.

Authors:  Jonathan R Grover; Sarah L Veatch; Akira Ono
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

Review 3.  Innate immune evasion by filoviruses.

Authors:  Christopher F Basler
Journal:  Virology       Date:  2015-04-03       Impact factor: 3.616

4.  Mechanism of Tetherin Inhibition of Alphavirus Release.

Authors:  Judy J Wan; Yaw Shin Ooi; Margaret Kielian
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

5.  UL26 Attenuates IKKβ-Mediated Induction of Interferon-Stimulated Gene (ISG) Expression and Enhanced Protein ISGylation during Human Cytomegalovirus Infection.

Authors:  Christopher M Goodwin; Xenia Schafer; Joshua Munger
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

6.  Differential Control of BST2 Restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists Encoded by HIV-1 Group M and O Strains.

Authors:  Mariana G Bego; Lijun Cong; Katharina Mack; Frank Kirchhoff; Éric A Cohen
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

7.  Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.

Authors:  Markus Hoffmann; Inga Nehlmeier; Constantin Brinkmann; Verena Krähling; Laura Behner; Anna-Sophie Moldenhauer; Nadine Krüger; Julia Nehls; Michael Schindler; Thomas Hoenen; Andrea Maisner; Stephan Becker; Stefan Pöhlmann
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

8.  The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.

Authors:  Constantin Brinkmann; Inga Nehlmeier; Kerstin Walendy-Gnirß; Julia Nehls; Mariana González Hernández; Markus Hoffmann; Xiangguo Qiu; Ayato Takada; Michael Schindler; Stefan Pöhlmann
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

9.  The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release.

Authors:  Abdul A Waheed; Maya Swiderski; Ali Khan; Ariana Gitzen; Ahlam Majadly; Eric O Freed
Journal:  J Biol Chem       Date:  2020-04-14       Impact factor: 5.157

Review 10.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.